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Loss of functional MYO1C/myosin 1c, a motor
protein involved in lipid raft trafﬁcking, disrupts
autophagosome-lysosome fusion
Hemma Brandstaetter,1,y Chieko Kishi-Itakura,1,y David A Tumbarello,1,3,y Dietmar J Manstein,2 and Folma Buss1,*
1Cambridge Institute for Medical Research; University of Cambridge; Cambridge, UK; 2Institute for Biophysical Chemistry; Hannover Medical School; Hannover, Germany;
3Center for Biological Sciences; University of Southampton; Highﬁeld Campus; Southampton, UK
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Abbreviations: BafA1, bafilomycin A1; EM, electron microscopy; EGF, epidermal growth factor; EGFR, epidermal growth factor
receptor; GFP, green fluorescent protein; KD, knockdown; LAMP1, lysosomal-associated membrane protein 1; LC3, microtubule-
associated protein 1 light chain 3; MYO1C, myosin IC; MVB, multivesicular body; PB, phosphate buffer; PCIP, pentachloropseudi-
lin; PtdIns(4, 5)P2, phosphatidylinositol 4, 5-bisphosphate; RFP, red fluorescent protein; RPE, retinal pigment epithelium.
MYO1C, a single-headed class I myosin, associates with cholesterol-enriched lipid rafts and facilitates their recycling
from intracellular compartments to the cell surface. Absence of functional MYO1C disturbs the cellular distribution of
lipid rafts, causes the accumulation of cholesterol-enriched membranes in the perinuclear recycling compartment, and
leads to enlargement of endolysosomal membranes. Several feeder pathways, including classical endocytosis but also
the autophagy pathway, maintain the health of the cell by selective degradation of cargo through fusion with the
lysosome. Here we show that loss of functional MYO1C leads to an increase in total cellular cholesterol and its disrupted
subcellular distribution. We observe an accumulation of autophagic structures caused by a block in fusion with the
lysosome and a defect in autophagic cargo degradation. Interestingly, the loss of MYO1C has no effect on degradation
of endocytic cargo such as EGFR, illustrating that although the endolysosomal compartment is enlarged in size, it is
functional, contains active hydrolases, and the correct pH. Our results highlight the importance of correct lipid
composition in autophagosomes and lysosomes to enable them to fuse. Ablating MYO1C function causes abnormal
cholesterol distribution, which has a major selective impact on the autophagy pathway.
Introduction
Autophagy is a cellular degradation pathway to maintain cel-
lular homeostasis in times of starvation and to eliminate long-
lived or misfolded proteins, damaged organelles as well as cyto-
solic pathogens. In this process, cytoplasmic components are first
sequestered within a specialized double-membrane vesicle termed
the autophagosome. The autophagosome receives input from
early and late endosomes in a stepwise maturation process to
form an amphisome, which can then fuse with lysosomes to
acquire the full set of hydrolases that enable content
degradation.1,2
In mammalian cells, autophagosome-lysosome fusion depends
on a variety of different factors including the small GTPase
RAB7, the actin cytoskeleton as a tethering component, and also
the correct lipid composition of the autophagosomal or lyso-
somal membrane.3,4 The importance of the correct lipid content
was demonstrated through in vitro studies using isolated auto-
phagosomes and lysosomes from animals challenged with a high-
fat diet, which significantly changed the lipid composition of
autophagosomes and lysosomes, thus leading to a reduction in
their cholesterol content and a defect in autophagosome-lyso-
some fusion.4 However, not only lower levels of lysosomal cho-
lesterol, but also the accumulation of this lipid in lysosomes, as
seen in many different lysosomal storage diseases, reduces deliv-
ery of autophagic content to lysosomes.5
To further investigate the importance of cellular lipids for the
regulation of autophagic activity, we analyzed whether changes in
the cellular distribution of sphingolipid- and cholesterol-enriched
lipid microdomains (herein referred to as lipid rafts) has an
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impact on efficient substrate degradation via autophagy. Our pre-
vious work identified MYO1C, a member of class I myosins, as a
key regulator of trafficking of lipid rafts from intracellular storage
compartments to the plasma membrane.6 MYO1C is a slow
monomeric actin-based motor protein, adapted for sustained
power mobility that links membrane cargo enriched in
phospholipids, such as phosphatidylinositol 4,5-bisphosphate
(PtdIns[4,5]P2), to the actin cytoskeleton. Membrane targeting
of MYO1C involves a putative PH-domain present in the short
C-terminal tail.7,8 This myosin motor is predominantly enriched
in dynamic regions of the plasma membrane characterized by the
presence of lamellipodia, filopodia, and membrane ruffles.9 In
addition, MYO1C is
recruited onto highly
dynamic lipid-raft
enriched membrane
tubules in the endocytic
recycling pathway, where
it is required for delivery
and exocytosis of lipid-
raft enriched membranes
at the plasma mem-
brane.6,10 This function
is supported by the find-
ing that MYO1C facili-
tates the exocytosis and
delivery of several raft-
associated cargoes such as
SLC2A4/GLUT4,11,12
AQP2/aquaporin 2,13
KIRREL/NEPH114 as
well as KDR/VEGFR215
to the cell surface. At the
cellular level, ablating
MYO1C function results
in a redistribution of
lipid-raft enriched
domains from the plasma
membrane to intracellular
compartments and an
accumulation of these
membranes in the perinu-
clear region.6 In addition,
we also observed a very
significant change in the
morphology of late endo-
cytic organelles in the
form of enlarged swollen
lysosomes following loss
of MYO1C.16
Here, we demonstrate
that changes in cellular
cholesterol trafficking in
MYO1C-depleted cells
cause a significant
increase in total intracel-
lular cholesterol content.
In cells missing func-
tional MYO1C we
observe a selective defect
in autophagosome- and
amphisome-lysosome
Figure 1. For ﬁgure legend, see page 2312.
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fusion resulting in the accumulation of autophagic structures
(phagophores, autophagosomes, and amphisomes), while the
delivery and degradation of endogenous endocytic cargo such as
the EGFR is not affected. Interestingly, although the loss of this
myosin leads to morphological changes in endolysosomes, the
enlarged organelles show no change in pH or in activity of lyso-
somal hydrolases. In summary, our results highlight the impor-
tance of MYO1C-dependent lipid trafficking for
autophagosome-lysosome fusion, subsequent clearance of auto-
phagic organelles, and degradation of mutant HTT/huntingtin
protein aggregates via the autophagy pathway.
Results
Loss of MYO1C causes accumulation of autophagosomes
The loss of MYO1C function results in redistribution of
marker proteins that are associated with sphingolipid- and cho-
lesterol-enriched lipid rafts, from the plasma membrane to intra-
cellular compartments.6 Since disturbance of the cellular lipid
balance, distribution, and membrane composition have a strong
impact on the autophagy pathway,4,5 we investigated whether
the depletion of functional MYO1C, either by siRNA-mediated
knockdown (KD) or using the MYO1 inhibitor pentachlorop-
seudilin (PCIP),16 has an effect on autophagosome biogenesis or
degradation. To assess whether MYO1C is required for autoph-
agy progression, we quantified the number of LC3-positive auto-
phagosomes under basal conditions by immunofluorescence
microscopy in MYO1C KD cells (Fig. 1A–C). Quantifying
either the levels of endogenous LC3 (Fig. 1A) or using a stable
cell line expressing GFP-tagged LC3 (Fig. S1A), we observed an
accumulation of autophagosomes visualized by a 2-fold increase
in the LC3-signal measured by LC3-area/cell or total LC3-fluo-
rescence/cell (Fig. 1B and C; Fig. S1B, C, and D). The accumu-
lation of autophagosomes in MYO1C KD cells was confirmed
by measuring the amount of lipidated LC3-II in the presence or
absence of the vATPase inhibitor bafilomycin A1 (BafA1) by
immunoblotting. BafA1 inhibits the acidification of endocytic
structures and thereby blocks autophagosome-lysosome fusion.
Under steady state conditions, in the absence of BafA1, MYO1C
KD cells showed at least a 2-fold increase in the amount of LC3-
II and an accumulation of the autophagy cargo SQSTM1/p62 as
compared to mock-treated cells (Fig. 1 D and E; Fig. S1E). The
higher LC3-II levels in the absence of MYO1C were not linked
to an increase in autophagosome biogenesis, since there was no
increase in the accumulation of LC3-II in the presence of BafA1
in KD cells as compared to mock-treated cells (Fig. 1D, E and
F). In addition, we also analyzed the effect of MYO1C protein
depletion on MTOR signaling and autophagy activation in
response to amino-acid starvation. Our results clearly show inac-
tivation of MTOR signaling exhibited by the suppression of
phosphorylation of MTOR and its downstream target, RPS6KB/
p70S6K, in response to starvation in both mock- and MYO1C-
depleted cells (Fig. 1G).
To further analyze the autophagy defect in MYO1C KD cells,
we investigated the ultrastructural morphology of the accumu-
lated LC3-positive organelles by conventional electron micros-
copy. Examples of the different autophagic structures, which can
be classified according to their appearance as phagophores, auto-
phagosomes, amphisomes, and autolysosomes3 together with late
endocytic multivesicular bodies (MVBs), are highlighted by
arrowheads in Fig. 1H. The ultrastructural analysis showed an
increase in the number of amphisome/endolysosome-like organ-
elles in MYO1C-depleted cells compared to mock-transfected
cells (Fig. 1H). To confirm the identity of these organelles, con-
trol and MYO1C KD cells were labeled with antibodies to LC3
followed by silver-enhanced immunogold electron microscopy
(Fig. 1I). Whereas LC3-positive autophagosomes were present in
both control and MYO1C-depleted cells (Fig. 1I, a and b), LC3-
positive amphisomes, which are a fusion product of LC3-positive
autophagosomes and MVBs with numerous intralumenal vesicles
(Fig. 1I, c), were more abundant in MYO1C KD cells. These
results suggest a block late in the autophagy pathway and a
potential accumulation of autophagic structures due to a defect
in fusion with the lysosome.
The accumulation of LC3-positive autophagosomes, LC3-II,
and the autophagy cargo receptors, SQSTM1 and TAX1BP1
(Tax1 [human T-cell leukemia virus type I] binding protein 1),
was not only observed after siRNA depletion of MYO1C, but
also when cells were treated with the small molecule inhibitor
PCIP (Fig. 2A, B, C and D). This small molecule reduces the
binding affinity of MYO1C for F-actin in the presence of nucleo-
tide by binding in the cleft between the upper and lower 50-kDa
region in the motor domain.16 Treatment with 1 or 5 mM PCIP
for 16 h caused a dramatic increase in LC3-II (Fig. 2C and D);
the accumulation of double-membrane autophagosomes under
Figure 1 (See previous page). MYO1C depletion by siRNA causes accumulation of LC3-positive autophagosomes. (A) HeLa cells mock transfected or
transfected with siRNA speciﬁc toMYO1C were either cultured under normal growth conditions or amino acid starved for 2 h, and were labeled with anti-
bodies to endogenous LC3 for immunoﬂuorescence microscopy. Bars D 10 mm. (B, C) LC3-positive puncta were quantiﬁed by high-throughput micros-
copy. Automated imaging and analysis software was used to calculate the puncta area (B) and ﬂuorescence (C) per cell. A signiﬁcant increase in the LC3-
puncta area and ﬂuorescence was observed in MYO1C siRNA-treated cells as compared to control cells. A total number of >50 ,000 cells from 3 indepen-
dent experiments were analyzed. (D) For immunoblot analysis, control and MYO1C-depleted HeLa cells were either left untreated or treated with
100 nM baﬁlomycin A1 (BafA1) for 2 h. A representative blot is shown. (E) Quantiﬁcation of protein gel blots from 3 independent knockdown experi-
ments revealed an increase in LC3-II intensity upon MYO1C knockdown. (F) To determine the effect of MYO1C depletion on autophagosome biogenesis,
the fold increase in normalized LC3-II intensity from baﬁlomycin A1-treated to untreated samples was calculated. Graphs represent the means§ s.e.m.
(G) Control and MYO1C siRNA-depleted HeLa cells were amino acid starved for 2 h prior to processing for western blot analysis of MTOR signaling. (H)
HeLa cells were cultured for 2 h in starvation medium and analyzed by conventional electron microscopy. Arrowheads highlight the presence of differ-
ent autophagic and endocytic organelles. Bar D 500 nm. (I) Mock-treated and MYO1C-knockdown cells were labeled for immuno-electron microscopy
using anti-LC3 antibodies. Bar D 500 nm.
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basal conditions was also
observed by conventional
electron microscopy
(Fig. 2E). The nature of
these autophagic struc-
tures was verified by
immunolabeling with
anti-LC3 (Fig. 2F). A sig-
nificant increase in size of
these LC3-positive organ-
elles was observed in cells
treated with 1 mM and
even more in cells incu-
bated with 5 mM PCIP
(note the difference in
scale bars in Fig. 2F). To
further confirm that the
autophagy defect was
caused by the loss of
MYO1C and was not
due to off-target effects
that were linked to the
depletion of unrelated
proteins, we performed
KD experiments with the
4 individual siRNA oligo-
nucleotides. The KD of
MYO1C with each of the
single siRNAs resulted in
a similar accumulation of
autophagosomes as seen
by MYO1C depletion
using SMARTpool siRNA
or the inhibitor PCIP
(Fig. S2A). Collectively,
these results demonstrate
that a functional MYO1C
motor is required for
autophagy progression
under basal conditions,
but is not required for
autophagosome
formation.
Clearance of an
autophagy-dependent
cargo requires MYO1C
Autophagy may be a
potential therapeutic
approach for clearance of
misfolded proteins caused
by various pathologies,
including Huntington’s
disease. Therefore, we
assessed whether the
MYO1C loss-of-function
Figure 2. For ﬁgure legend, see page 2314.
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autophagy phenotype affects the autophagy-dependent clearance
of HTT/huntingtin-polyQ protein aggregates.17 We analyzed
whether loss of MYO1C expression has an effect on clearance of
HTT protein containing a pathological poly Q expansion, which
leads to misfolding and aggregation. We generated a HeLa cell
line stably expressing a GFP-tagged HTT protein with a N-ter-
minal 72 amino acid polyglutamine repeat (HTTQ72-GFP).18
In most cells this mutant form of HTT protein is cytosolic; only
a few cells (less than 20%) contained multiple HTT aggregates
(>15 /cell) (Fig. 3A, B). In contrast we observed a dramatic
increase in the number of cells (> 70%) exhibiting multiple
HTTQ72-GFP aggregates following MYO1C KD and PCIP
treatment (Fig. 3B). The accumulation of HTTQ72-GFP aggre-
gates and their colocalization with the autophagy receptor
SQSTM1 and the autophagosome marker LC3, following
MYO1C disruption, was consistent with the effects seen follow-
ing inhibition of autophagosome-lysosome fusion using BafA1
(Fig. 3A, B, C and D). In summary, our results support a role
for MYO1C in autophagy-dependent degradation of protein
aggregates.
MYO1C depletion leads to a defect in autophagosome-
lysosome fusion
Our data so far suggests that loss of functional MYO1C causes
a block in fusion of autophagic organelles with lysosomes. To
confirm this process in MYO1C KD cells, we used a pH-sensitive
LC3-reporter construct containing both an RFP and GFP fusion
tag at the N terminus.19 In this assay, the less acidic autophago-
somes appear yellow due to red and green fluorescence; however,
after fusion with a lysosome the drop in pH quenches the GFP-
signal, and thus autolysosomes appear red. Using this approach,
we found that in a stable HeLa cell line expressing the RFP-GFP-
LC3 reporter, the loss of MYO1C causes an accumulation of yel-
low autophagosomes under basal conditions (Fig. 4A). Quantifi-
cation following confocal microscopy revealed a significant
increase in overlap of the GFP/RFP fluorescence signal in
MYO1C KD cells compared to mock-transfected cells (Fig. 4B)
indicating that MYO1C depletion causes impaired autophago-
some-lysosome fusion. The LC3-positive autophagosomes and
amphisomes in MYO1C-depleted cells showed less overlap in
localization with CTSD/cathepsin D-positive lysosomes (labeled
by the lysosomal protease CTSD) when compared to untreated
control cells (Fig. 4C and D). This further confirms that loss of
MYO1C causes a defect in fusion of autophagic organelles with
lysosomes.
Loss of MYO1C causes a dramatic change in lysosome
morphology, but no change in the number of LAMP1-positive
organelles
To establish the cause of the inefficient delivery of auto-
phagic material to the lysosome, we next investigated lyso-
some morphology and function in MYO1C-depleted cells.
Our previous work demonstrated that ablating MYO1C func-
tion not only causes a dramatic cellular redistribution of cho-
lesterol-enriched lipid raft domains,6 but also leads to a
change in lysosomal morphology.16 Inhibition of MYO1C
expression or activity using either a SMARTpool of MYO1C-
specific siRNA (Fig. 5A and D), 4 single siRNA oligos
(Fig. S2B) or the inhibitor PCIP (Fig. 5A) induced the for-
mation of enlarged membrane structures, which contained
the lysosomal hydrolase CTSD and the lysosomal membrane
glycoprotein LAMP1. To further analyze the morphological
changes in the late endocytic pathway, we performed pre-
embedding immuno-electron microscopy of control and
MYO1C KD cells with antibodies to LAMP1. The electron
micrographs demonstrated that these enlarged LAMP1-posi-
tive structures (up to 2 mm in size) were morphologically
similar to endolysosomes (the hybrid organelle resulting from
late endosome-lysosome fusion),20 since they contained multi-
lamellar membrane whirls that are typically seen in lysosomes,
as well as different sizes of intralumenal vesicles often
observed in late endosomes (Fig. 5E; Fig. S3C). While evalu-
ation of LAMP1 by western blot only indicated slight fluctu-
ations in overall protein levels, quantification of LAMP1 by
light microscopy showed an increase in LAMP1-immunoreac-
tivity (Fig. 5B and C; Fig. S3A), which was linked to the
increase in size21 (Fig. S3D) and was not caused by an
increase in the number of LAMP1-positive organelles, which
stayed constant in the presence or absence of MYO1C
(Fig. S3B).
This result was confirmed by quantitative immuno-electron
microscopy, which also demonstrated no difference in the num-
ber of LAMP1-positive lysosomes or endolysosomes in control
and MYO1C KD cells under steady-state conditions (Fig. 5F).
However, after amino acid starvation, we observed a significant
accumulation in the number of LAMP1-negative amphisomes in
MYO1C KD cells (Fig. 5F; white arrowhead in Fig. 5E). Taken
together our results so far suggest that loss of functional MYO1C
increases the size but not the number of LAMP1- and CTSD-
positive endolysosomes and leads to an accumulation in the num-
ber of LAMP1-negative amphisomes.
Figure 2 (See previous page). Inhibition of MYO1C function by the small molecule inhibitor PCIP causes accumulation of LC3-positive autophagosomes.
(A) HeLa cells were incubated with 2 mM of the MYO1 inhibitor PCIP or equivalent amounts of DMSO for 16 h and processed for confocal microscopy
using antibodies against endogenous LC3. (B) LC3-positive vesicles in control and PClP-treated cells were quantiﬁed by high-throughput microscopy.
Automated imaging and analysis software revealed a signiﬁcant increase in the LC3 puncta ﬂuorescence per cell upon PClP treatment. A total number of
>41 ,000 cells from 3 independent experiments, each performed in duplicate, were analyzed. (C) Western blot analysis of HeLa cell lysates treated with
PCIP for 16 h in the absence or presence of 100 nM baﬁlomycin A1. (D) Quantiﬁcation of LC3-II, SQSTM1, and TAX1BP1 protein expression from protein
gel blots of PCIP-treated HeLa cells revealed a dose-dependent increase in LC3-II, SQSTM1, and TAX1BP1 levels. Results represent the mean (C/¡ s.d.)
from >3 independent experiments. (E) Conventional electron microscopy of HeLa cells treated with 1 mM PCIP for 16 h. Panels (b) and (d) represent
enlarged boxed regions in (a) and (b). Double arrows indicate autophagosomes and phagophores. Scale bar D 500 nm. (F) HeLa cells treated with PCIP
for 16 h were labeled for immuno-electron microscopy using anti-LC3 antibodies. Scale bar D 500 nm.
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The enlarged lysosomes in MYO1C-depeleted cells show no
defect in lysosomal activity
Enlarged late endocytic organelles are often observed in lyso-
somal storage disorders. In these diseases cholesterol and other
lipids accumulate in lysosomes, which may cause defects in
proteolytic activity or reduced ability of lysosomes to fuse with
endosomes or autophagosomes.22,23 To establish whether the
morphological changes associated with loss of MYO1C affect
the homeostasis and physiological activity of the enlarged lyso-
somes, we first used the pH-sensitive dye LysoTracker Red to
label acidic lysosomes in live cells.
Mock transfected and MYO1C KD
cells displayed very similar intensity
in LysoTracker Red staining, indicat-
ing no major change in lysosomal
acidity after loss of MYO1C
(Fig. 6A). After treatment with
BafA1, which inhibits acidification of
endosomes and lysosomes, we
observed a complete loss of Lyso-
Tracker Red signal (Fig. 6A). We
next determined whether these swol-
len lysosomes still perform their deg-
radative functions by analyzing
proteolytic activity of lysosomal
cathepsin in MYO1C-depleted cells.
We measured intracellular cathepsin
activity directly in lysosomes using an
artificial commercial cathepsin-sub-
strate peptide (Magic Red TM), which
is linked to the fluorophore cresyl
violet and emits a red fluorescence
signal at 550–590 nm after enzymatic
cleavage. Using this artificial sub-
strate, we observed in situ no differ-
ence in cathepsin-activity, measured
as the amount of red fluorescent sig-
nal, between mock or MYO1C KD
cells (Fig. 6B and C). Finally, we
used EGFR (epidermal growth factor
receptor) as an endogenous substrate
to monitor lysosomal activity. EGFR
is a typical member of the receptor
tyrosine kinase family, which after
ligand binding-induced activation is
endocytosed and delivered to lyso-
somes for degradation. Following
stimulation of control and MYO1C
KD cells with EGF for 1, 2 or 3 h to
induce internalization and trafficking
of the receptor to lysosomes, the rate
of EGFR degradation was assessed by
immunoblotting. Consistent with our
results from the cathepsin activity
assay, no defect in ligand-induced
EGFR degradation was observed after
loss of functional MYO1C (Fig. 6D).
Taken together, these data demon-
strate that, although absence of
MYO1C causes dramatic changes in
endolysosomal morphology, this has
Figure 3. For ﬁgure legend, see page 2316.
www.landesbioscience.com 2315Autophagy
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 C
am
br
idg
e] 
at 
08
:35
 10
 Fe
br
ua
ry
 20
15
 
no effect on lysosomal function and degradation of endocytic
cargo.
MYO1C KD cells display defects in intracellular cholesterol
distribution
Since ablating MYO1C expression causes the redistribution of
lipid rafts from the plasma membrane to an intracellular com-
partment, we next investigated whether there was an abnormal
distribution of cholesterol-enriched membranes in MYO1C KD
cells. A similar phenotype can be observed in lysosomal storage
diseases, such as Niemann-Pick disease type C, which is linked to
an increase of cellular cholesterol and glycolipids concentrated in
swollen lysosomes. To measure cellular cholesterol levels and
visualize cholesterol-positive content in cells, we used the fluores-
cent dye filipin, which stains unesterified cholesterol in situ and
thereby illuminates intracellular cholesterol storage organelles.
We evaluated filipin fluorescence by confocal microscopy and
quantified total filipin fluorescence in mock-transfected and
MYO1C KD cells as well as in DMSO-treated or PCIP-treated
cells using automated microscopy (Fig. 7A and B). The results
shown in Figures 7A and B clearly demonstrate that, similar to
Niemann-Pick disease type C, the overall cellular cholesterol lev-
els were significantly increased in MYO1C-depleted cells. In con-
trol cells, filipin-staining was present on the cell surface and on
intracellular organelles, which showed some overlap with
LAMP1 (Fig. 7A; Fig. S4). In MYO1C KD cells, however, most
of the filipin staining was redistributed from the plasma mem-
brane to intracellular compartments, but did not exhibit a prefer-
ential accumulation in a LAMP1-positive compartment (Fig. 7A;
Fig. S4). These results suggest that loss of MYO1C function
causes intracellular mistrafficking of cholesterol-enriched mem-
branes, thus resulting in an accumulation and aberrant distribu-
tion of cholesterol.
Discussion
Here we report that loss of MYO1C function specifically
inhibits clearance of autophagosomes and sequestered protein
aggregates, but does not impair degradation of endocytic cargo.
After loss of functional MYO1C, we observe a set of distinct phe-
notypes: the accumulation of autophagic organelles, suggesting a
block in autophagy progression, and the formation of swollen
LAMP1 as well as CTSD-positive endolysosomes (summarized
in our model shown in Fig. 7C). In addition, our previous work
demonstrated that MYO1C-depleted cells show redistribution of
cholesterol and sphingolipid-enriched lipid rafts from the plasma
membrane and accumulation of these lipids in intracellular mem-
brane compartments.6 This defect in intracellular cholesterol traf-
ficking leads to an accumulation of total cellular cholesterol
(Fig. 7).
The reduction in autophagosome degradation could be
caused by either (1) a defect in autophagosome maturation,
(2) reduced proteolytic activity of the lysosomal enzymes or
(3) impaired autophagosome fusion with the lysosome. We
investigated these different possibilities and found no obvious
defect in delivery and degradation of endocytic cargo in lyso-
somes; the endocytic pathway required during autophagosome
maturation is fully functional, since we observed the accumu-
lation of amphisomes, which are hybrid organelles composed
of late endosomes/MVBs and autophagosomes, in MYO1C-
knockdown cells. Furthermore, no changes in lysosomal pH
or reduction in proteolytic activity were observed when mea-
suring cathepsin activity using a reporter substrate or when
analyzing the degradation of endogenous endocytic reporter
molecules such as EGFR. These results demonstrate that loss
of MYO1C does not impair endolysosomal or lysosomal
activity. This leaves us with the third possibility, a reduction
in fusion of autophagosomes with the late endocytic proteo-
lytic compartment, which would explain the defect in auto-
phagic cargo degradation and the observed increase in the
number of these amphisome-like organelles.
The absence of functional MYO1C leads to the formation
of enlarged late endocytic and/or lysosomal structures, which
contain LAMP1 as well as CTSD. Ultrastructural analysis
highlights the presence of lysosomal membrane whirls as well
as large numbers of intralumenal vesicles; these are morpholog-
ical characteristics typically found in endolysosomes, the hybrid
organelle formed by late endosome/MVB fusion with a lyso-
some, which provides the degradative enzymes to make the
hybrid organelles competent for proteolysis.20,24 It is thought
that membranes are retrieved from this hybrid organelle by
vesicle trafficking to counterbalance the constant membrane
influx from the endocytic pathway. This may also provide a
pathway for the reformation of the classical dense core lyso-
some, which is the storage compartment for lysosomal hydro-
lases.20 It has been suggested that PtdIns(4,5)P2 regulates
lysosome reformation following autophagy activation.25,26
Since MYO1C contains a PtdIns(4,5)P2-specific PH domain,
we evaluated whether loss of MYO1C affects PtdIns(4,5)P2 on
Figure 3 (See previous page). Protein aggregate clearance by selective autophagy requires MYO1C. (A) HeLa cells stably expressing HTTQ72-GFP were
transfected with siRNA targeting MYO1C or treated with 1 mM PCIP, alongside appropriate controls, and labeled for immunoﬂuorescence using antibod-
ies to GFP. Bar D 10 mm. (B) HTTQ72-GFP aggregates were quantiﬁed in mock-, MYO1C siRNA-, DMSO-, 1 mM PCIP-, and 100 nM baﬁlomycin A1-treated
cells. The results are represented as the percentage of HTTQ72-GFP-expressing cells with more than 15 GFP-positive spots per cell. MYO1C knockdown
and PCIP treatment lead to a signiﬁcant increase in the number of cells containing HTTQ72-GFP aggregates. Graphs represent the means§ s.e.m from 3
independent experiments. A total number of >3900 cells was analyzed. (C) HeLa cells stably expressing HTTQ72-GFP were treated with 100 nM baﬁlo-
mycin A1 for 16 h prior to processing for immunoﬂuorescence microscopy. Scale bar D 20 mm. (D) HeLa cells stably expressing HTTQ72-GFP were
treated with 1 mM PCIP for 16 h prior to processing for immunoﬂuorescence microscopy using antibodies to the indicated proteins. Nuclei in blue were
labeled with Hoechst. Scale bar D 20 mm.
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the plasma membrane using a GFP-PLCD/PLCd-PH probe.
Our results indicate no apparent difference in PtdIns(4,5)P2
on the plasma membrane in MYO1C KD or PCIP-treated
cells (Fig. S5).
The accumulation of these swollen endolysosomes in MYO1C
KD and PCIP-treated cells may be linked to abnormal cholesterol
levels in this LAMP1-positive compartment, which can change
membrane properties and may reduce membrane retrieval from
Figure 4. MYO1C depletion leads to defects in autophagosome-lysosome fusion. (A) HeLa cells stably expressing the RFP-GFP-LC3 reporter were either
mock- or MYO1C siRNA-transfected and analyzed by confocal immunoﬂuorescence. Single channel images of boxed regions are indicated to the right of
merged color image. Cell nuclei are shown in blue. Bars D 10 mm. (B) The GFP/RFP signal overlap from confocal images of control and MYO1C knock-
down cells expressing RFP-GFP-LC3 is represented as the Pearson’s coefﬁcient. A total number of>1000 cells from 3 independent experiments were ana-
lyzed. (C) Control and MYO1C siRNA-treated RPE cells stably expressing GFP–LC3 were stained with antibodies against GFP and CTSD for confocal
microscopy. The inserts are enlarged representations of the boxed regions. Bars D 10 mm. (D) Quantiﬁcation of GFP-LC3/CTSD signal overlap from confo-
cal images of control and MYO1C knockdown RPE cells expressing GFP-LC3 is represented as the Pearson’s coefﬁcient. The decreased signal correlation
in siRNA-treated cells conﬁrms a role for MYO1C in autophagosome/lysosome fusion. Graph represents the means§ s.e.m.
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this organelle. Alternatively, MYO1C might have a direct function
in membrane budding from endolysosomes, similar to its postu-
lated role in cargo sorting and vesicle/tubule formation at the peri-
nuclear recycling compartment.27 Although we are not able to
detect significant amounts of MYO1C on LAMP1-positive organ-
elles under steady-state conditions, previous reports show that over-
expression of VPS18, a component of the mammalian HOPS
complex, causes clustering of late endosomes and/or lysosomes in
actin-rich areas and recruitment of MYO1C to these
compartments.28 These results suggest
that MYO1C may indeed be able to
associate with endolysosomes, however,
under steady-state conditions the recruit-
ment of a limited number of MYO1C
motors from the cytosolic pool might be
transient and therefore difficult to detect
by standard immunofluorescence
microscopy.
In a number of lysosomal storage dis-
eases, including Niemann-Pick type C
disease, defects in cholesterol and lipid
trafficking lead to accumulation of lipids
in late endocytic compartments, which
results in a strong inhibitory effect on
autophagosome clearance.23,29,30 Our
results are consistent with previous studies
that demonstrated a dramatic reduction
in autophagosome-lysosome fusion in vitro, when levels of cholesterol
in the membrane of autophagosomes or lysosomes were changed
either by chemical treatment of isolated organelles or by feeding ani-
mals a high-fat diet before isolating the organelles for in vitro fusion
assays.4 Although themolecular mechanism of how lipid content reg-
ulates autophagosome-lysosome fusion remains to be determined, it
is likely that changes in cholesterol levels have an impact on mem-
brane rigidity or fluidity. This will change the physical parameters of
the lipid bilayer surrounding the autophagosome, endolysosome, and
Figure 5. Effect of MYO1C knockdown on
lysosome morphology. HeLa cells were
either mock treated or transfected with
MYO1C siRNA or incubated for 16 h with
the MYO1 inhibitor PClP or equivalent
amounts of DMSO as control before proc-
essing for confocal microscopy (A, D) or
western blot analysis (B) using antibodies
against the lysosomal marker proteins
LAMP1 or the lysosomal protease CTSD.
Bar D 10 mm. (C) Quantiﬁcation of LAMP1
protein levels from protein gel blots fol-
lowing MYO1C siRNA depletion or PCIP
treatment. Results represent the mean
(C/¡ s.d.) from >3 independent experi-
ments. (E) Mock-treated or MYO1C siRNA
KD cells in complete medium were
labeled for immuno-electron microscopy
using anti-LAMP1 antibodies. Black arrow-
heads indicate LAMP1-positive amphi-
somes and the white arrowhead indicates
a LAMP1-negative amphisome. Bar D
500 nm. (F) Graph showing the quantiﬁca-
tion of the number of LAMP1-positive or
-negative lysosomes (Ly) or amphisomes
(Am)/endolysosomes (EL) from at least 56
randomly selected areas, from each cell,
for each condition in control or MYO1C
KD cells growing in complete medium or
under starvation conditions. Each data
point indicates one cell.
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lysosome and thus affect the lateral dynamics and availability ofmem-
brane proteins required for the fusion process.
Interestingly, although close links exist between endocytosis and
autophagy and many of the regulatory factors and machinery are
shared between the 2 pathways,31 loss of MYO1C and the resulting
changes in lipid composition selectively inhibit autophagosome-
lysosome fusion, but do not inhibit delivery, fusion, and degradation
of endocytic cargo in the endolysosome or lysosome. Therefore, the
Figure 6. For ﬁgure legend, see page 2320.
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data presented in this work support the model whereby fusion of
autophagosomes with lysosomes utilizes a specific mechanism that is
distinct from other fusion events in the endocytic pathway. Differen-
ces between the mechanism of autophagosomal-lysosomal and
endosomal-lysosomal fusion is also highlighted by experiments
using the drug thapsigargin, which selectively inhibits autophago-
some-lysosome fusion, while having no effect on the degradation of
endocytic cargo. 32
In summary, this work clearly highlights that different myosin
motor proteins have very distinct functions along the autophagy
pathway. Our previous work demonstrated that MYO6/myosin
VI and its adaptor protein TOM1 are required for delivery of
early endosomes to the autophagosome,18 a process recognized to
be important during autophagosome maturation.33,34 In con-
trast, MYO1C regulates intracellular trafficking of cholesterol-
enriched membranes and deletion of this motor may cause a
change in the lipid composition of autophagic and late endocytic
organelles, which has a clear impact on the fusion efficiency
between these compartments. In addition, the separate functions
of MYO1C and MYO6 in the autophagy pathway may be due to
their different motor properties; MYO6 although also a slow
myosin, exists as a monomer or dimer, and moves toward the
minus end of actin filaments, whereas MYO1C is a slow mono-
meric myosin, which moves toward the plus end of actin fila-
ments. Thus in the cell these 2 motors might perform distinct
functions required for the operation of the autophagy pathway.
Materials and Methods
Antibodies
The following commercial antibodies were used: rabbit poly-
clonal antibodies to GFP (Invitrogen, A11122), MYO1C
(Sigma-Aldrich, HPA001768), EGFR (Santa Cruz Biotechnol-
ogy, 1005 sc-03); mouse monoclonal antibodies to GFP (Abcam,
ab 1218), LC3 (MBL International, M152–3), SQSTM1 (BD
Biosciences, 610832), LAMP1 (Developmental Studies Hybrid-
oma Bank, University of Iowa, H4A3-c), TUBA4A/tubulin
(Sigma-Aldrich, T9026), CTSD/cathepsinD (BD Biosciences,
610800), FLOT1/flotillin 1 (BD Biosciences, 610820), FLOT2/
flotillin2 (BD Biosciences, 610383), phospho-Thr389 RPS6KB/
p70S6 kinase (Cell Signaling Technology, 9206), RPS6KB/
p70S6 kinase (Cell Signaling Technology, 9202), phospho-
Ser2448 MTOR (Cell Signaling Technology, 2971), MTOR
(Cell Signaling Technology, 2972). Alexa Fluor 488- and 568-
conjugated secondary antibodies were from Invitrogen (A21429
and A11029).
Cell culture, siRNA transfection, and drug treatment
HeLaM cells35 were cultured in RPMI 1640 medium (Sigma,
R8758) and retinal pigment epithelium (RPE) cells in 50:50
DMEM:F12 Ham medium (Sigma, D6429 and N4888) supple-
mented with 30 mM sodium bicarbonate, all containing 10%
fetal calf serum, 2 mM L-glutamine, 100 U/ml penicillin and
100 mg/ml streptomycin in a 5% humidified atmosphere. As
described and characterized previously18 RPE cells stably express-
ing GFP-LC3 and HeLa RFP-GFP-LC3 cell lines were created
using pIRESneo2 plasmids, selected in medium containing 500
mg/ml G418 (Gibco, 10131–027); and the HTTQ72-GFP sta-
ble HeLa cells line was generated using the Lent-X Lentiviral
expression system (Clontech, 631247). The GFP-PLCD-PH sta-
ble expressing HeLa cells were generated using the GFP-C1-
PLCD/PLCdelta-PH plasmid (Addgene, 21179) developed by
Tobias Meyer (Stauffer, 1998), following selection in G418.
All siRNA oligos (ON-TARGETplus single oligos and
SMARTpool) were obtained from Dharmacon. For successful
protein depletion, cells were transfected twice with siRNA on d 1
and 3 using OligofectAMINE (Invitrogen, 12252–011). On d 5
cells were processed for the indicated assays. Protein knockdown
efficiency was assessed by immunoblotting.
Bafilomycin A1 (used at a final concentration of 100 nM, 2 h)
was purchased from Sigma-Aldrich (B1793), and the MG132
inhibitor (used at 1 mM for 2 h) from Millipore (CAS 133407–
82–6). Cells were incubated with 3 mM U18666A drug (Milli-
pore, 662015) for 16 h. The MYO1C inhibitor PClP, a kind
gift of H.-J. Kn€olcker (Technical University of Dresden), was
used at a concentration of 1–5 mM in DMSO for 16 h, as previ-
ously described.21
EGFR degradation assay
Control and knockdown HeLa cells were serum starved over-
night, incubated with 100 mg/ml cycloheximide (Sigma, C4859)
for 2 h before stimulation with 100 ng/ml EGF (Sigma, E9644).
Cells were lysed at the indicated time points and lysates were
blotted as described below.
Immunoblotting
Cells were washed in PBS (Sigma, D8537) and lysed in 6 M
urea-SDS loading buffer (2% SDS, 30% glycerol, 1 M b-mer-
captoethanol, 6 M urea, 0.125 M Tris, pH 6.8, 0.01% bromo-
phenol blue), and separated by SDS-PAGE followed by
immunoblot analysis with the indicated antibodies. Western
blots were developed using the ECL detection reagents (GE
Healthcare, RPN2106V1 and V2). Quantitative
Figure 6 (See previous page). Analysis of lysosome function in MYO1C-depleted cells. (A) Mock, MYO1C-depleted cells, and baﬁlomycin A1-treated cells
were incubated with the LysoTracker Red probe and imaged using live cell microscopy to monitor lysosomal pH. Swollen lysosomes in MYO1C knock-
down cell appear to be acidic. (B) To determine lysosomal enzyme activity in live cells control and MYO1C-depleted HeLa cells were incubated with
Magic Red. Confocal microscopy was used to image cathepsin–associated hydrolysis of Magic Red into its red ﬂuorescent form. (C) Calculation of cathep-
sin activity using Volocity Imaging software revealed no signiﬁcant difference between cathepsin activity in control and MYO1C-knockdown cells. Values
are means § s.e.m from 3 independent experiments (>1900 cells). ns, not signiﬁcant. (D) To measure EGFR degradation in control and MYO1C siRNA-
treated HeLa cells, cells were serum-starved overnight, and incubated with 100 mg/ml cycloheximide for 2 h before stimulating with 100 ng/ml EGF for
0, 1, 2 and 3 h. EGFR levels were quantiﬁed from immunoblots and normalized to a loading control. No signiﬁcant difference in the rate of EGFR degrada-
tion was observed in control and knockdown cells. Values are means§ s.e.m from 3 independent knockdown experiments.
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immunoblotting was performed following protein transfer to
ImmobilonFL PVDF membranes (Millipore, IPFL00010) and
incubation with Alexa Fluor 680-conjugated secondary antibod-
ies (Invitrogen, 926–32212D and 926–32213D), before scan-
ning on a LI-COR Odyssey Imaging system (LI-COR
Biosciences). Following background correction, the integrated
intensity of proteins of interest bands were normalized to a load-
ing control before quantification.
Immunofluorescence microscopy
Cells plated on coverslips were fixed with 4% paraformalde-
hyde (or cold methanol for CTSD labeling), permeabilized with
Figure 7. For ﬁgure legend, see page 2322.
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0.2% Triton X-100 (BDH, 306324N) and quenched with
10 mM glycine. To reduce cytosolic background cells were
extracted with 0.02% saponin (Sigma, F47036) for 30 sec before
fixation. Fixed cells were blocked with 1% BSA (Fisher Scientific,
BP1605–100) in PBS and processed for indirect immunofluores-
cence using the indicated primary antibodies followed by Alexa
Fluor 488- or Alexa Fluor 568-coupled secondary antibodies. F-
actin was visualized using Alexa Fluor 568-coupled phalloidin
(Sigma Aldrich, A12380) and cell nuclei were stained with
Hoechst (Invitrogen, H3570). To visualize cholesterol, nonper-
meabilized cells were labeled with freshly prepared filipin-com-
plex (Sigma, F4767) in DMSO at a final concentration of 25
mg/ml. The MagicRed CathepsinB Assay Kit (ImmunoChemis-
try Technologies, 937) was used following the manufacturer’s
instructions.
Images were obtained at a magnification of 63x using a Zeiss
LSM710 confocal microscope or a Zeiss Axioplan epifluores-
cence (Zeiss), equipped with a Hamamatsu Orca R2 camera
(Hamamatsu Photonics). To analyze colocalization, the Pearson’s
coefficient was calculated from confocal images using the Voloc-
ity 5.2 software (Perkin Elmer).
Automated quantification
ArrayScan VTi 6.6.1.4 HighContentScreening microscope
and software (Cellomics) were used for the automated quanti-
fication of lysosome number/cell, LAMP1 intensity, total cho-
lesterol levels/cell and autophagosome size. Cells were either
seeded into 96-well view plates (Perkin Elmer, 6005182) or
on glass coverslips, and processed for immunofluorescence as
described above using the indicated antibodies and Hoechst
stain to identify each individual cell. Images were captured
using a 20£ or 40£ lens and analysis was performed with the
Cellomics Spot Detector V4 or Target activation V4 algorithm
applications.
Electron microscopy
HeLa cells were cultured on collagen-coated plastic cover-
slips (Sumitomo Bakelite, MS-0113 KZ) and fixed in 2.5%
glutaraldehyde in 0.1 M sodium phosphate buffer, pH 7.4
(phosphate buffer, PB) for 2 h. The cells were then washed
3 times in PB, before post-fixing for 1 h in 1% osmium
tetroxide in 0.1 M PB. The fixed cells were then dehydrated
and embedded in Agar 100 resin (Agar Scientific, R1030)
according to a standard protocol.36 Ultrathin sections were
stained with uranyl acetate and lead citrate and observed
under a FEI Tecnai Spirit electron microscope (FEI, Hills-
boro, Oregon, USA).
For immunoelectron microscopy analysis of endogenous LC3
and LAMP1, cells were fixed with 4% paraformaldehyde in
0.1 M PB for 2 h on ice. After washing 3 times with PB, the cells
were permeabilized in liquid nitrogen, before blocking with
0.005% saponin, 10% BSA, 10% normal goat serum (Sigma,
G9023), and 0.1% cold water fish skin gelatin (Sigma, G7765)
in PB.37 Cells were incubated with mouse monoclonal anti-LC3
(Cosmo Bio, CTB-LC3–2–1C; diluted 10£) or mouse mono-
clonal anti-LAMP1 (diluted 250£) in blocking solution over-
night. The cells were then washed in PB containing 0.005%
saponin several times and incubated for 2 h with goat anti-mouse
IgG conjugated to colloidal gold (1.4 nm diameter; Nanoprobes,
2002). Cells were washed with PB and fixed with 1% glutaralde-
hyde in PB for 10 min. After washing, the gold labeling was
intensified (6 min at room temperature) by using a gold enhance-
ment kit (Nanoprobes, 2113). After washing in distilled water,
cells were postfixed in 1% OsO4 containing potassium ferrocya-
nide for 60 min at 4C, washed in distilled water, incubated
with 30% ethanol for 10 min, 50% ethanol 10 min and stained
with 2% uranyl acetate in 70% ethanol for 2 h. The cells were
further dehydrated with a graded series of ethanol and were
embedded in Agar 100 resin. Ultrathin sections were double
stained with uranyl acetate. 37
Statistical significance
Comparisons between 2 data sets were performed using the
Student t test, between 3 or more data points using ANOVA
combined with post-hoc Bonferroni’s multiple comparison test
(GraphPad Prism 5.01).
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Figure 7 (See previous page). MYO1C-depleted cells contain more total cellular cholesterol, trapped in intracellular storage compartments. (A) Confocal
z-projection microscopy images of cellular cholesterol, imaged with ﬁlipin, from mock andMYO1C siRNA-depleted HeLa cells. Scale barD 20 mm (B) Total
cholesterol levels in mock and MYO1C-knockdown cells and DMSO- and PClP-treated cells were quantiﬁed by high-throughput microscopy. Automated
imaging and analysis software was used to calculate the total ﬁlipin ﬂuorescence per cell. Loss of MYO1C caused a signiﬁcant increase in cholesterol as
compared to control cells. In total >149 ,000 cells from 3 independent experiments, each performed in triplicate, were analyzed. Graphs represent the
means§ s.e.m. (C) Model of the autophagy and endocytic pathway highlighting defects (shown in blue) observed in MYO1C-depleted cells. Loss of func-
tional MYO1C causes a defect in lipid raft recycling from the perinuclear recycling compartment back to the cell surface. This leads to intracellular accu-
mulation of cholesterol-enriched membranes.6 In the classical endocytic pathway, incoming cargo ﬁrst moves through early endosomes, which then
acquire an increasing number of intralumenal vesicles and mature into late endosomes (LE)/multivesicular bodies (MVB). The fusion of a LE/MVB with a
lysosome generates a transient hybrid organelle, the endolysosome, in which content degradation can take place. In MYO1C-depleted cells, we observe
the accumulation of enlarged LAMP1- and CTSD-positive endolysosomes. In the autophagy pathway, cytosolic material is sequestered by expansion and
closure of a phagophore, forming double-membrane vesicles called autophagosomes. These autophagosomes mature by fusion with early and late
endosomes to form an intermediate organelle called the amphisome, which fuses with lysosomes to enable content degradation. Ablating MYO1C activ-
ity leads to an accumulation in the number of autophagic structures suggesting a block in fusion of autophagic organelles with lysosomes.
2322 Volume 10 Issue 12Autophagy
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 C
am
br
idg
e] 
at 
08
:35
 10
 Fe
br
ua
ry
 20
15
 
Acknowledgments
We thank J. Kendrick-Jones for many helpful discussions and
comments on the manuscript and A. Kruppa and E. Itakura for
critical reading of the manuscript. The MYO1C inhibitor, PClP,
was kindly provided by Hans-Joachim Kn€olcker (Technical Uni-
versity of Dresden).
Funding
This work was financially supported by the Wellcome Trust
(F.B., D.A.T. and H.B.), the Deutsche Forschungsgemeinschaft
Grant MA 1081/19–1 (D.J.M) and the Medical Research Coun-
cil (F.B and C. K.-I.). The CIMR is in receipt of a strategic award
from the Wellcome Trust (100140).
References
1. Weidberg H, Shvets E, Elazar Z. Biogenesis and cargo
selectivity of autophagosomes. Annu Rev Biochem
2011; 80:125-56; PMID:21548784; http://dx.doi.org/
10.1146/annurev-biochem-052709-094552
2. Mizushima N, Komatsu M. Autophagy: renovation of
cells and tissues. Cell 2011; 147:728-41;
PMID:22078875; http://dx.doi.org/10.1016/j.
cell.2011.10.026
3. Mizushima N, Yoshimori T, Levine B. Methods in
mammalian autophagy research. Cell 2010; 140:313-
26; PMID:20144757; http://dx.doi.org/10.1016/j.
cell.2010.01.028
4. Koga H, Kaushik S, Cuervo AM. Altered lipid content
inhibits autophagic vesicular fusion. FASEB J 2010;
24:3052-65; PMID:20375270; http://dx.doi.org/
10.1096/fj.09-144519
5. Fraldi A, Annunziata F, Lombardi A, Kaiser HJ,
Medina DL, Spampanato C, Fedele AO, Polishchuk R,
Sorrentino NC, Simons K, et al. Lysosomal fusion and
SNARE function are impaired by cholesterol accumula-
tion in lysosomal storage disorders. EMBO J 2010;
29:3607-20; PMID:20871593; http://dx.doi.org/
10.1038/emboj.2010.237
6. Brandstaetter H, Kendrick-Jones J, Buss F. Myo1c reg-
ulates lipid raft recycling to control cell spreading,
migration and Salmonella invasion. J Cell Sci 2012;
125:1991-2003; PMID:22328521; http://dx.doi.org/
10.1242/jcs.097212
7. Hokanson DE, Laakso JM, Lin T, Sept D, Ostap EM.
Myo1c binds phosphoinositides through a putative
pleckstrin homology domain. Mol Biol Cell 2006;
17:4856-65; PMID:16971510; http://dx.doi.org/
10.1091/mbc.E06-05-0449
8. Hokanson DE, Ostap EM. Myo1c binds tightly and
specifically to phosphatidylinositol 4,5-bisphosphate
and inositol 1,4,5-trisphosphate. Proc Natl Acad Sci U
S A 2006; 103:3118-23; PMID:16492791; http://dx.
doi.org/10.1073/pnas.0505685103
9. Ruppert C, Godel J, Muller RT, Kroschewski R, Rein-
hard J, Bahler M. Localization of the rat myosin I mole-
cules myr 1 and myr 2 and in vivo targeting of their tail
domains. J Cell Sci 1995; 108 (Pt 12):3775-86;
PMID:8719884
10. Bose A, Robida S, Furcinitti PS, Chawla A, Fogarty K,
Corvera S, Czech MP. Unconventional myosin Myo1c
promotes membrane fusion in a regulated exocytic
pathway. Mol Cell Biol 2004; 24:5447-58;
PMID:15169906; http://dx.doi.org/10.1128/
MCB.24.12.5447-5458.2004
11. Chen XW, Leto D, Chiang SH, Wang Q, Saltiel AR.
Activation of RalA is required for insulin-stimulated
Glut4 trafficking to the plasma membrane via the exo-
cyst and the motor protein Myo1c. Dev Cell 2007;
13:391-404; PMID:17765682; http://dx.doi.org/
10.1016/j.devcel.2007.07.007
12. Munnich S, Taft MH, Manstein DJ. Crystal structure
of human myosin 1c–the motor in GLUT4 exocytosis:
implications for Ca2C regulation and 14-3-3 binding. J
Mol Biol 2014; 426:2070-81; PMID:24636949;
http://dx.doi.org/10.1016/j.jmb.2014.03.004
13. Barile M, Pisitkun T, Yu MJ, Chou CL, Verbalis MJ,
Shen RF, Knepper MA. Large scale protein identifica-
tion in intracellular aquaporin-2 vesicles from renal
inner medullary collecting duct. Mol Cell Proteomics
2005; 4:1095-106; PMID:15905145; http://dx.doi.
org/10.1074/mcp.M500049-MCP200
14. Arif E, Wagner MC, Johnstone DB, Wong HN,
George B, Pruthi PA, Lazzara MJ, Nihalani D. Motor
protein Myo1c is a podocyte protein that facilitates the
transport of slit diaphragm protein Neph1 to the podo-
cyte membrane. Mol Cell Biol 2011; 31:2134-50;
PMID:21402783; http://dx.doi.org/10.1128/
MCB.05051-11
15. Tiwari A, Jung JJ, Inamdar SM, Nihalani D, Choud-
hury A. The myosin motor Myo1c is required for
VEGFR2 delivery to the cell surface and for angiogenic
signaling. Am J Physiol Heart Circ Physiol 2013; 304:
H687-96; PMID:23262137; http://dx.doi.org/
10.1152/ajpheart.00744.2012
16. Chinthalapudi K, Taft MH, Martin R, Heissler SM,
Preller M, Hartmann FK, Brandstaetter H, Kendrick-
Jones J, Tsiavaliaris G, Gutzeit HO, et al. Mechanism
and specificity of pentachloropseudilin-mediated inhi-
bition of myosin motor activity. J Biol Chem 2011;
286:29700-8; PMID:21680745
17. Scherzinger E, Lurz R, Turmaine M, Mangiarini L,
Hollenbach B, Hasenbank R, Bates GP, Davies SW,
Lehrach H, Wanker EE. Huntingtin-encoded polyglut-
amine expansions form amyloid-like protein aggregates
in vitro and in vivo. Cell 1997; 90:549-58;
PMID:9267034; http://dx.doi.org/10.1016/S0092-
8674(00)80514-0
18. Tumbarello DA, Waxse BJ, Arden SD, Bright NA,
Kendrick-Jones J, Buss F. Autophagy receptors link
myosin VI to autophagosomes to mediate Tom1-
dependent autophagosome maturation and fusion with
the lysosome. Nat Cell Biol 2012; 14:1024-35;
PMID:23023224; http://dx.doi.org/10.1038/ncb2589
19. Kimura S, Noda T, Yoshimori T. Dissection of the
autophagosome maturation process by a novel reporter
protein, tandem fluorescent-tagged LC3. Autophagy
2007; 3:452-60; PMID:17534139; http://dx.doi.org/
10.4161/auto.4451
20. Bright NA, Reaves BJ, Mullock BM, Luzio JP. Dense
core lysosomes can fuse with late endosomes and are re-
formed from the resultant hybrid organelles. J Cell Sci
1997; 110 (Pt 17):2027-40; PMID:9378754
21. Chinthalapudi K, Taft MH, Martin R, Heissler SM,
Preller M, Hartmann FK, Brandstaetter H, Kendrick-
Jones J, Tsiavaliaris G, Gutzeit HO, et al. Mechanism
and specificity of pentachloropseudilin-mediated inhi-
bition of myosin motor activity. J Biol Chem 2011;
286:29700-8; PMID:21680745; http://dx.doi.org/
10.1074/jbc.M111.239210
22. Simons K, Gruenberg J. Jamming the endosomal sys-
tem: lipid rafts and lysosomal storage diseases. Trends
Cell Biol 2000; 10:459-62; PMID:11050411; http://
dx.doi.org/10.1016/S0962-8924(00)01847-X
23. Lieberman AP, Puertollano R, Raben N, Slaugenhaupt
S, Walkley SU, Ballabio A. Autophagy in lysosomal
storage disorders. Autophagy 2012; 8:719-30;
PMID:22647656; http://dx.doi.org/10.4161/
auto.19469
24. Griffiths G, Hoflack B, Simons K, Mellman I, Kornfeld
S. The mannose 6-phosphate receptor and the biogene-
sis of lysosomes. Cell 1988; 52:329-41;
PMID:2964276; http://dx.doi.org/10.1016/S0092-
8674(88)80026-6
25. Yu L, McPhee CK, Zheng L, Mardones GA, Rong Y,
Peng J, Mi N, Zhao Y, Liu Z, Wan F, et al. Termina-
tion of autophagy and reformation of lysosomes regu-
lated by mTOR. Nature 2010; 465:942-6;
PMID:20526321; http://dx.doi.org/10.1038/
nature09076
26. Rong Y, Liu M, Ma L, Du W, Zhang H, Tian Y, Cao
Z, Li Y, Ren H, Zhang C, et al. Clathrin and phospha-
tidylinositol-4,5-bisphosphate regulate autophagic lyso-
some reformation. Nat Cell Biol 2012; 14:924-34;
PMID:22885770; http://dx.doi.org/10.1038/ncb2557
27. Brandstaetter H, Kendrick-Jones J, Buss F. Molecular
roles of Myo1c function in lipid raft exocytosis. Com-
mun Integr Biol 2012; 5:508-10; PMID:23739769;
http://dx.doi.org/10.4161/cib.21201
28. Poupon V, Stewart A, Gray SR, Piper RC, Luzio JP.
The role of mVps18p in clustering, fusion, and intra-
cellular localization of late endocytic organelles. Mol
Biol Cell 2003; 14:4015-27; PMID:14517315; http://
dx.doi.org/10.1091/mbc.E03-01-0040
29. Ko DC, Milenkovic L, Beier SM, Manuel H,
Buchanan J, Scott MP. Cell-autonomous death of cere-
bellar purkinje neurons with autophagy in Niemann-
Pick type C disease. PLoS Genet 2005; 1:81-95;
PMID:16103921; http://dx.doi.org/10.1371/journal.
pgen.0010081
30. Sarkar S, Carroll B, Buganim Y, Maetzel D, Ng AH,
Cassady JP, Cohen MA, Chakraborty S, Wang H,
Spooner E, et al. Impaired autophagy in the lipid-stor-
age disorder Niemann-Pick type C1 disease. Cell Rep
2013; 5:1302-15; PMID:24290752; http://dx.doi.org/
10.1016/j.celrep.2013.10.042
31. Lamb CA, Dooley HC, Tooze SA. Endocytosis and
autophagy: Shared machinery for degradation. Bioes-
says 2013; 35:34-45; PMID:23147242; http://dx.doi.
org/10.1002/bies.201200130
32. Ganley IG, Wong PM, Gammoh N, Jiang X. Distinct
autophagosomal-lysosomal fusion mechanism revealed
by thapsigargin-induced autophagy arrest. Mol Cell
2011; 42:731-43; PMID:21700220; http://dx.doi.org/
10.1016/j.molcel.2011.04.024
33. Filimonenko M, Stuffers S, Raiborg C, Yamamoto A,
Malerod L, Fisher EM, Isaacs A, Brech A, Stenmark H,
Simonsen A. Functional multivesicular bodies are
required for autophagic clearance of protein aggregates
associated with neurodegenerative disease. J Cell Biol
2007; 179:485-500; PMID:17984323; http://dx.doi.
org/10.1083/jcb.200702115
34. Orsi A, Polson HE, Tooze SA. Membrane trafficking
events that partake in autophagy. Curr Opin Cell Biol
2010; 22:150-6; PMID:20036114; http://dx.doi.org/
10.1016/j.ceb.2009.11.013
35. Tiwari RK, Kusari J, Sen GC. Functional equivalents of
interferon-mediated signals needed for induction of an
mRNA can be generated by double-stranded RNA and
growth factors. EMBO J 1987; 6:3373-8;
PMID:2828026
36. Hara T, Takamura A, Kishi C, Iemura S, Natsume T,
Guan JL, Mizushima N. FIP200, a ULK-interacting
protein, is required for autophagosome formation in
mammalian cells. J Cell Biol 2008; 181:497-510;
PMID:18443221; http://dx.doi.org/10.1083/
jcb.200712064
37. Yoshimori T, Yamagata F, Yamamoto A, Mizushima
N, Kabeya Y, Nara A, Miwako I, Ohashi M, Ohsumi
M, Ohsumi Y. The mouse SKD1, a homologue of yeast
Vps4p, is required for normal endosomal trafficking
and morphology in mammalian cells. Mol Biol Cell
2000; 11:747-63; PMID:10679028; http://dx.doi.org/
10.1091/mbc.11.2.747
www.landesbioscience.com 2323Autophagy
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 C
am
br
idg
e] 
at 
08
:35
 10
 Fe
br
ua
ry
 20
15
 
